Free Newsletter
Study: Januvia plays well with metformin
Free newsletter via e-mail
Tools
Merck's new diabetes drug Januvia delivered good blood sugar control over two years of treatment in combination with the older drug metformin, according to a new study the company is touting at the European Associaiton for the Study of Diabetes meeting. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: